A Signal Assay for the Detection of Genotoxic Compounds: Application on the Urines of Cancer Patients on Chemotherapy and of Nurses Handling Cytotoxic Drugs
Restricted accessResearch articleFirst published online November, 1988
A Signal Assay for the Detection of Genotoxic Compounds: Application on the Urines of Cancer Patients on Chemotherapy and of Nurses Handling Cytotoxic Drugs
1 The excretion of thioethers was determined in the urine of nurses handling cytotoxic drugs (n = 10) and cancer patients under chemotherapy (n = 32).
2 An occupational non-exposed group served as control (n = 28).
3 We found no association between the handling of cytotoxic drugs and occupational exposure of nurses. Cancer patients under chemotherapy showed abnormally high values of thioethers, while urinary thioether concentration was, consistently, rather low in some individuals under intensive chemotherapy.
4 We conclude that periodical urinary thioether determinations should be made available to hospital staff as well as cancer patients to minimize the risks of the cytotoxic drugs.
Get full access to this article
View all access options for this article.
References
1.
Iarc.Some Antineoplastic and Immunosuppressive Agents, vol. 26, pp. 37-384. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon: IARC, 1981.
2.
Lien EJ & Ou X.Carcinogenicity of some anticancer drugs—a survey. Journal of Clinical and Hospital Pharmacy1985; 10: 223-42.
3.
Harris CCImmunosuppressive anticancer drugs in man: their oncogenic potential. Radiology1975; 114: 163-6.
4.
Wall RL & Clausen KPCarcinoma of the urinary bladder in patients receiving cyclophosphamide. New England Journal of Medicine1975; 293: 271-3.
5.
Rosner F.Acute leukemia as a delayed consequence of cancer chemotherapy. Cancer1976; 37: 1033-6.
6.
Reimer RR, Hoover R., Fraumeni JF & Young RCAcute leukemia after alkylating agent therapy of ovarian cancer. New England Journal of Medicine1977; 297: 177-81.
7.
Berk PD, Goldberg JD, Silverstein MN, et al. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. New England Journal of Medicine1981; 304: 441-7.
8.
Falck K., Gröhn P., Sorsa M., Vainio H., Heinonen E. & Holsti LRMutagenicity in urine of nurses handling cytostatic drugs. Lancet1979; i: 1250-1.
9.
Anderson RW, Puckett WH, Dana WJ, Nguyen TV, Theiss JC & Matney TSRisk of handling injectable antineoplastic agents. American Journal of Hospital. Pharmacy1982; 39: 1881-7.
10.
Waksvik H., Klepp O. & Brogger A.Chromosome analyses of nurses handling cytostatic agents. Cancer Treatment Reports1981; 65: 607-10.
11.
Norppa H., Sorsa M., Vainio H., et al. Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scandinavian Journal of Work, Environment and Health1980; 6: 299-301.
12.
Jagun O., Ryan M. & Waldron HAUrinary thioether excretion in nurses handling cytotoxic drugs. Lancet1982ii: 443-4.
13.
Bayhan A., Burgaz S. & Karakaya AEUrinary thioether excretion in nurses at an oncologic department. Journal of Clinical Pharmacy and Therapeutics1987; 12: 303-6.
14.
Iarc.Monitoring Human Exposure to Carcinogenic and Mutagenic Agents, IARC Scientific Publications No. 59 . Lyon: IARC, 1984.
15.
Van Doorn R. , Leijdekkers ChM , Bos RP, Brounds Rme & Henderson PTh.Detection of human exposure to electrophilic compounds by assay of thioether detoxication products in urine. Annals of Occupational Hygiene1981 ; 24: 77-92.
16.
Seutter-Berlage F., Selten Gcm, Ooostendorp Sgml & Hoog Antink Jmt.The modified thioether test. In Chemical Porphyria in Man, eds JJTWA Strik & JH Koeman.Amsterdam: Elsevier/North-Holland Biomedical Press , 1979.
17.
Donald M. & Zimmer A.Atlas of Clinical Laboratory Procedures, volume 1. New York: Blakiston Division, McGraw-Hill, 1967.
18.
Hirst M., Tse S., Mills DG, Levin L. & White DFOccupational exposure to cyclophosphamide. Lancet1984; i: 186-8.
19.
Staiano N., Gallelli JF, Adamson RH & Thorgeirsson SSLack of mutagenic activity in urine from hospital pharmacists admixing antitumour drugs. Lancet1981; ii: 615-6.
20.
Venitt S., Crofton-Sleigh C., Hunt J., Speechley V. & Briggs K.Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption. Lancet1984; i: 74-7.
21.
Neal AW, Wadden RA & Chiou WLExposure of hospital workers to airborne antineoplastic agents. American Journal of Hospital Pharmacy1983; 40: 597-601.
22.
Triebig G., Moser S. & Schaller KHPilot study for the diagnostic validity of urinary thioether excretion in occupational medicine. Zentralblatt fuer Arbeitsmedizin1986; 36: 301-7.
23.
Chasseaud LFThe role of glutathione and glutathione S transferases in the metabolism of chemical carcinogens and other electrophilic agents. Advances in Cancer Research1979; 29: 175-255.
